A decrease in plasma glucose levels is required for increased endogenous glucose production with a single administration of an SGLT2 inhibitor tofogliflozin
| Image |  |
|---|---|
| Description | scientific article published on 29 December 2020 |
| Author/s |
author: Hirotaka Watada Yoshifumi Tamura |
| Publication date | December 29, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |